Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis
Errataetall: |
CommentOn: J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104989. - PMID 32689590 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
---|---|
Enthalten in: |
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association - 29(2020), 12 vom: 07. Dez., Seite 105222 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kow, Chia Siang [VerfasserIn] |
---|
Links: |
---|
Themen: |
9005-49-6 |
---|
Anmerkungen: |
Date Completed 07.12.2020 Date Revised 14.01.2021 published: Print-Electronic CommentOn: J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104989. - PMID 32689590 Citation Status MEDLINE |
---|
doi: |
10.1016/j.jstrokecerebrovasdis.2020.105222 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM314642358 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM314642358 | ||
003 | DE-627 | ||
005 | 20231225153153.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jstrokecerebrovasdis.2020.105222 |2 doi | |
028 | 5 | 2 | |a pubmed24n1048.xml |
035 | |a (DE-627)NLM314642358 | ||
035 | |a (NLM)32891494 | ||
035 | |a (PII)S1052-3057(20)30640-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kow, Chia Siang |e verfasserin |4 aut | |
245 | 1 | 0 | |a Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.12.2020 | ||
500 | |a Date Revised 14.01.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentOn: J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104989. - PMID 32689590 | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 4 | |a Comment | |
650 | 4 | |a Anticoagulant | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Cerebral venous Thrombosis | |
650 | 4 | |a Heparin | |
650 | 7 | |a Anticoagulants |2 NLM | |
650 | 7 | |a Heparin |2 NLM | |
650 | 7 | |a 9005-49-6 |2 NLM | |
700 | 1 | |a Zaihan, Abdullah Faiz |e verfasserin |4 aut | |
700 | 1 | |a Hasan, Syed Shahzad |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association |d 1991 |g 29(2020), 12 vom: 07. Dez., Seite 105222 |w (DE-627)NLM090676726 |x 1532-8511 |7 nnns |
773 | 1 | 8 | |g volume:29 |g year:2020 |g number:12 |g day:07 |g month:12 |g pages:105222 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2020.105222 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 29 |j 2020 |e 12 |b 07 |c 12 |h 105222 |